Form 4 for ALKS Alkermes plc.
Accepted 2025-01-31 00:00:00 ET · period of report 2025-01-30 · accession 0001127602-25-002645 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-31 | 2025-01-30 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $22.22 | +97.6K | 76.7K | New | +$2.17M |
| D | 2025-01-31 | 2025-01-30 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | S - Sale+OE | $32.05 | -100.9K | 44.3K | -69% | -$3.23M |
| DM | 2025-01-31 | 2025-01-30 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $0.00 | -97.6K | 161.7K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-01-30 | M | A | 18,345 | $26.82 | 145,208 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-01-30 | S | D | 100,918 | $32.05 | 44,290 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.17. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. |
| 3 | Common | Ordinary Shares | 2025-01-30 | M | A | 23,542 | $24.59 | 126,863 | D | — | — | |
| 4 | Common | Ordinary Shares | 2025-01-30 | M | A | 26,589 | $19.34 | 103,321 | D | — | — | |
| 5 | Common | Ordinary Shares | 2025-01-30 | M | A | 29,156 | $20.03 | 76,732 | D | — | — | |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2025-01-30 | M | D | 18,345 | $0.00 | 92,271 | D | $26.82 · — to 2033-02-23 | 18,345 Ordinary Shares | (F7) Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2025-01-30 | M | D | 23,542 | $0.00 | 106,758 | D | $24.59 · — to 2032-02-18 | 23,542 Ordinary Shares | (F6) Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2025-01-30 | M | D | 29,156 | $0.00 | 87,566 | D | $20.03 · — to 2030-02-20 | 29,156 Ordinary Shares | (F4) These options are fully vested in accordance with their terms. |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2025-01-30 | M | D | 26,589 | $0.00 | 161,734 | D | $19.34 · — to 2031-02-22 | 26,589 Ordinary Shares | (F5) Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022. |